Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed CFO
Director departure
Quarterly results
Appointed director

Cardiff Oncology, Inc. (TROV) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/16/2023 4 Smeal Tod (Chief Scientific Officer) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 167,088 options @ $1.72, valued at $287.4k
03/16/2023 4 Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 197,472 options @ $1.72, valued at $339.7k
03/16/2023 4 Kelemen Vicki (Exec. VP and COO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 125,520 options @ $1.72, valued at $215.9k
03/16/2023 4 Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 482,064 options @ $1.72, valued at $829.2k
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 13,000 shares @ $1.5564, valued at $20.2k
09/20/2022 4 White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 15,000 shares @ $1.635, valued at $24.5k
09/19/2022 4 TANNENBAUM RENEE P (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 6,400 shares @ $1.715, valued at $11k
Bought 3,600 shares @ $1.72, valued at $6.2k
09/19/2022 4 PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 150,000 shares @ $1.71, valued at $256.5k
09/19/2022 4 Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 30,000 shares @ $1.557, valued at $46.7k
07/06/2022 4 White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Exercised 28,858 shares @ $2.6, valued at $75k
Exercised 28,858 options @ $2.6, valued at $75k
06/09/2022 4 BRANCACCIO JOHN P (Former Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Acquired 26,800 options @ $2.5, valued at $67k
Acquired 22,000 options @ $7.98, valued at $175.6k
Acquired 28,858 options @ $2.6, valued at $75k
Acquired 44,734 options @ $2.48, valued at $110.9k
Acquired 755 options @ $21.6, valued at $16.3k
Acquired 530 options @ $51.84, valued at $27.5k
Acquired 223 options @ $372.96, valued at $83.2k
Acquired 223 options @ $516.96, valued at $115.3k
Acquired 195 options @ $316.08, valued at $61.6k
03/11/2022 4 PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
03/10/2022 4 White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
03/10/2022 4 TANNENBAUM RENEE P (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
03/10/2022 4 Ruffner Katherine L (Chief Medical Officer) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 170,016 options @ $2.5, valued at $425k
03/10/2022 4 Mohindru Mani (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
03/10/2022 4 Markin Rodney S (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
03/10/2022 4 Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 170,016 options @ $2.5, valued at $425k
03/10/2022 4 Kelemen Vicki (Exec. VP and COO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 170,016 options @ $2.5, valued at $425k
03/10/2022 4 Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 370,128 options @ $2.5, valued at $925.3k
03/10/2022 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
03/10/2022 4 Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
09/22/2021 4 PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 30,000 shares @ $6.75, valued at $202.5k
09/13/2021 4 Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 5,000 shares @ $6.62, valued at $33.1k
Bought 5,000 shares @ $6.75, valued at $33.8k
Bought 10,000 shares @ $6.38, valued at $63.8k
Bought 5,000 shares @ $6.35, valued at $31.8k
Bought 5,000 shares @ $6.32, valued at $31.6k
07/14/2021 4 Ruffner Katherine L (Chief Medical Officer) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 200,000 options @ $6.55, valued at $1.3M
07/12/2021 4 Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 390,000 options to buy @ $6.55, valued at $2.6M
06/15/2021 4 JACOB GARY S (Former Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Acquired 28,858 options @ $2.6, valued at $75k
Acquired 293 options @ $447.84, valued at $131.2k
Acquired 218 options @ $316.08, valued at $68.9k
Acquired 223 options @ $516.96, valued at $115.3k
Acquired 223 options @ $372.96, valued at $83.2k
Acquired 530 options @ $51.84, valued at $27.5k
Acquired 755 options @ $21.6, valued at $16.3k
Acquired 44,734 options @ $2.48, valued at $110.9k
06/14/2021 4 White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 22,000 options @ $7.98, valued at $175.6k
06/14/2021 4 TANNENBAUM RENEE P (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 44,001 options @ $7.98, valued at $351.1k
06/14/2021 4 PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 22,000 options @ $7.98, valued at $175.6k
06/14/2021 4 Mohindru Mani (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 44,001 options @ $7.98, valued at $351.1k
06/14/2021 4 Markin Rodney S (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 22,000 options @ $7.98, valued at $175.6k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy